AU2005237394B2 - Use of a viscoelastic composition for treating increased intraocular pressure - Google Patents

Use of a viscoelastic composition for treating increased intraocular pressure Download PDF

Info

Publication number
AU2005237394B2
AU2005237394B2 AU2005237394A AU2005237394A AU2005237394B2 AU 2005237394 B2 AU2005237394 B2 AU 2005237394B2 AU 2005237394 A AU2005237394 A AU 2005237394A AU 2005237394 A AU2005237394 A AU 2005237394A AU 2005237394 B2 AU2005237394 B2 AU 2005237394B2
Authority
AU
Australia
Prior art keywords
fistula
viscoelastic medium
eye
viscoelastic
medium according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2005237394A
Other languages
English (en)
Other versions
AU2005237394A1 (en
Inventor
Bengt Agerup
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Q Med AB
Original Assignee
Q Med AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Q Med AB filed Critical Q Med AB
Publication of AU2005237394A1 publication Critical patent/AU2005237394A1/en
Application granted granted Critical
Publication of AU2005237394B2 publication Critical patent/AU2005237394B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Liquid Crystal (AREA)
  • Liquid Crystal Display Device Control (AREA)
AU2005237394A 2004-05-05 2005-05-04 Use of a viscoelastic composition for treating increased intraocular pressure Ceased AU2005237394B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0401182-1 2004-05-05
SE0401182A SE0401182D0 (sv) 2004-05-05 2004-05-05 Novel use of a viscoelastic composition
PCT/SE2005/000663 WO2005105037A2 (en) 2004-05-05 2005-05-04 Use of a viscoelastic composition for treating increased intraocular pressure

Publications (2)

Publication Number Publication Date
AU2005237394A1 AU2005237394A1 (en) 2005-11-10
AU2005237394B2 true AU2005237394B2 (en) 2009-12-10

Family

ID=32466229

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005237394A Ceased AU2005237394B2 (en) 2004-05-05 2005-05-04 Use of a viscoelastic composition for treating increased intraocular pressure

Country Status (12)

Country Link
US (1) US8721622B2 (cg-RX-API-DMAC7.html)
EP (1) EP1796624B1 (cg-RX-API-DMAC7.html)
JP (1) JP4922158B2 (cg-RX-API-DMAC7.html)
AT (1) ATE506940T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005237394B2 (cg-RX-API-DMAC7.html)
CA (1) CA2565382C (cg-RX-API-DMAC7.html)
DE (1) DE602005027718D1 (cg-RX-API-DMAC7.html)
ES (1) ES2365621T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA06012615A (cg-RX-API-DMAC7.html)
RU (1) RU2398566C2 (cg-RX-API-DMAC7.html)
SE (1) SE0401182D0 (cg-RX-API-DMAC7.html)
WO (1) WO2005105037A2 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7909789B2 (en) 2006-06-26 2011-03-22 Sight Sciences, Inc. Intraocular implants and methods and kits therefor
US20080089923A1 (en) * 2006-09-29 2008-04-17 Burkstrand Michael J Biodegradable ocular implants and methods for treating ocular conditions
US8703119B2 (en) 2007-10-05 2014-04-22 Polygene Ltd. Injectable biodegradable polymer compositions for soft tissue repair and augmentation
US8083720B2 (en) * 2008-05-13 2011-12-27 Solar Matthew S Device and method for delivering therapeutic agents to an area of the body
US9339514B2 (en) * 2008-09-12 2016-05-17 Aptissen Sa Method for treating glaucoma
US8715266B2 (en) * 2008-09-12 2014-05-06 Aptissen Sa Glaucoma surgery
MX2011008683A (es) * 2009-02-19 2011-09-06 Teijin Ltd Hidrogel de derivados de polisacarido.
JP5856569B2 (ja) 2010-02-05 2016-02-10 サイト サイエンシーズ， インコーポレイテッド 眼内圧を低減するためのデバイスと、それを含むキット
US8430862B2 (en) * 2010-04-08 2013-04-30 KMG Pharma LLC Subconjunctival agent delivery apparatus, system and method
US8574217B2 (en) 2010-04-08 2013-11-05 Kmg Pharma, Llc Sub-mucosal agent delivery method for the eye
US8652118B2 (en) 2010-04-08 2014-02-18 Kmg Pharma, Llc Sub-mucosal agent delivery, apparatus, system and method
RU2432141C1 (ru) * 2010-08-30 2011-10-27 Александр Геннадьевич Савенков Применение ирригационной жидкости в офтальмохирургии
RU2460517C1 (ru) * 2011-07-14 2012-09-10 Федеральное государственное учреждение "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Фармацевтическая композиция для комплексного лечения заболеваний глазной поверхности у больных с первичной открытоугольной глаукомой
US9095412B2 (en) 2012-03-20 2015-08-04 Sight Sciences, Inc. Ocular delivery systems and methods
KR101869988B1 (ko) * 2013-03-27 2018-06-21 주식회사 엘지화학 점탄성 히알루론산 가교물 제조용 조성물, 및 이를 이용하여 얻은 히알루론산 가교물
US9782247B2 (en) * 2014-02-18 2017-10-10 Cook Medical Technologies, LLC Flexible embolic double filter
US10299958B2 (en) 2015-03-31 2019-05-28 Sight Sciences, Inc. Ocular delivery systems and methods
ES2777836T3 (es) 2017-05-17 2020-08-06 Tx Medic Ab Tratamiento del glaucoma
US20210260300A1 (en) * 2018-06-01 2021-08-26 Sun Pharma Advanced Research Company Limited An injection device
US11504270B1 (en) 2019-09-27 2022-11-22 Sight Sciences, Inc. Ocular delivery systems and methods

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992000745A1 (en) * 1990-07-03 1992-01-23 Autogenesis Technologies, Inc. Collagen-based viscoelastic solution for visco-surgery
US5360425A (en) * 1990-08-17 1994-11-01 Candela Laser Corporation Sclerostomy method and apparatus

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2774239A (en) 1952-07-26 1956-12-18 Wisconsin Alumni Res Found Apparatus for determining dynamic mechanical properties of viscoelastic materials
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4965253A (en) * 1987-10-14 1990-10-23 University Of Florida Viscoelastic material for ophthalmic surgery
US5066276A (en) * 1988-06-21 1991-11-19 Alcon Laboratories, Inc. Method and apparatus for injecting viscous fluid into the eye to lift pre-retinal and post-retinal membrane with linear pressure control
US4955883A (en) 1988-08-29 1990-09-11 Diversatronics Glaucoma needle with a thermal heat band
US5092837A (en) 1989-12-20 1992-03-03 Robert Ritch Method for the treatment of glaucoma
US5360399A (en) 1992-01-10 1994-11-01 Robert Stegmann Method and apparatus for maintaining the normal intraocular pressure
US5273056A (en) * 1992-06-12 1993-12-28 Alcon Laboratories, Inc. Use of combinations of viscoelastics during surgery
US5707643A (en) * 1993-02-26 1998-01-13 Santen Pharmaceutical Co., Ltd. Biodegradable scleral plug
US5811453A (en) 1994-12-23 1998-09-22 Alcon Laboratories, Inc. Viscoelastic compositions and methods of use
US5827937A (en) * 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
US6142969A (en) 1996-10-25 2000-11-07 Anamed, Inc. Sutureless implantable device and method for treatment of glaucoma
US20020111603A1 (en) 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
FR2756493B1 (fr) * 1996-12-02 2001-04-13 Delab Dispositif d'administration locale de formulations solides ou semi-solides
FR2759577B1 (fr) 1997-02-17 1999-08-06 Corneal Ind Implant de sclerectomie profonde
DK0999854T3 (da) 1997-07-29 2004-02-09 Alcon Mfg Ltd Omskiftelige viskoelastiske systemer, der indeholder galactomannanpolymerer og -borater
US6378526B1 (en) * 1998-08-03 2002-04-30 Insite Vision, Incorporated Methods of ophthalmic administration
JP4551563B2 (ja) 1998-11-10 2010-09-29 電気化学工業株式会社 ヒアルロン酸ゲルの製造方法及び医用材料
WO2000059516A1 (en) * 1999-04-02 2000-10-12 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use in reducing adhesions
US6558342B1 (en) 1999-06-02 2003-05-06 Optonol Ltd. Flow control device, introducer and method of implanting
KR100855740B1 (ko) * 1999-12-10 2008-09-03 아이싸이언스 인터벤셔날 코포레이션 안 질환의 치료방법
US20030211166A1 (en) 2001-07-31 2003-11-13 Yamamoto Ronald K Microparticulate biomaterial composition for medical use
US6375642B1 (en) 2000-02-15 2002-04-23 Grieshaber & Co. Ag Schaffhausen Method of and device for improving a drainage of aqueous humor within the eye
US6638239B1 (en) * 2000-04-14 2003-10-28 Glaukos Corporation Apparatus and method for treating glaucoma
ATE298256T1 (de) * 2000-07-31 2005-07-15 Iscience Corp Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung
FR2819722B1 (fr) 2001-01-19 2006-11-24 Corneal Ind Utilisation de l'acide hyaluronique ou d'au moins l'un de ses sels dans le cadre d'un traitemnet chirurgical de la presbytie
EP1539066B1 (en) 2002-09-17 2012-11-07 Iscience Surgical Corporation Apparatus surgical bypass of aqueous humor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992000745A1 (en) * 1990-07-03 1992-01-23 Autogenesis Technologies, Inc. Collagen-based viscoelastic solution for visco-surgery
US5360425A (en) * 1990-08-17 1994-11-01 Candela Laser Corporation Sclerostomy method and apparatus

Also Published As

Publication number Publication date
WO2005105037A3 (en) 2006-05-18
CA2565382A1 (en) 2005-11-10
US8721622B2 (en) 2014-05-13
SE0401182D0 (sv) 2004-05-05
JP2007536220A (ja) 2007-12-13
US20080058760A1 (en) 2008-03-06
MXPA06012615A (es) 2007-01-31
JP4922158B2 (ja) 2012-04-25
WO2005105037A2 (en) 2005-11-10
ATE506940T1 (de) 2011-05-15
CA2565382C (en) 2013-12-03
ES2365621T3 (es) 2011-10-07
EP1796624B1 (en) 2011-04-27
DE602005027718D1 (de) 2011-06-09
EP1796624A2 (en) 2007-06-20
AU2005237394A1 (en) 2005-11-10
WO2005105037A8 (en) 2006-12-21
RU2398566C2 (ru) 2010-09-10
RU2006142861A (ru) 2008-06-20

Similar Documents

Publication Publication Date Title
CA2565382C (en) Use of a viscoelastic composition for treating increased intraocular pressure
JP5996526B2 (ja) 極微針を使用した、眼組織への薬物送達のための方法および装置
US20050277864A1 (en) Injectable gel implant for glaucoma treatment
JP4551563B2 (ja) ヒアルロン酸ゲルの製造方法及び医用材料
US4983585A (en) Viscoelastic fluid for use in surgery and other therapies and method of using same
AU2001245522C1 (en) Apparatus and method for treating glaucoma
US5068225A (en) Viscoelastic fluid for use in surgery and other therapies and method of using same
NL2004047C2 (en) An ophthalmic surgical device and a method of performing ophthalmic surgery.
US20040254520A1 (en) Coil implant for glaucoma treatment
US8715266B2 (en) Glaucoma surgery
US9339514B2 (en) Method for treating glaucoma
Qin et al. Development and material characteristics of glaucoma surgical implants
CN116133663A (zh) 具有高前列腺酰胺负载量的眼内植入物
Hoopes Sodium hyaluronate (Healon®) in anterior segment surgery: A review and a new use in extracapsular surgery
RS54013B1 (sr) Viskoelastični gelovi u oftamološkoj hirurgiji
EP4149400B1 (en) Methods and compositions for reducing intraocular pressure
Van der Veen et al. The gonioseton, a surgical treatment for chronic glaucoma
RU2297815C1 (ru) Способ хирургического лечения рефракторных глауком
RU2297816C1 (ru) Способ хирургического лечения рефрактерных глауком
RU2228160C2 (ru) Способ лечения рецидивирующей цилиохориоидальной отслойки после антиглаукоматозной операции
RU2557925C1 (ru) Биодеградируемый многослойный имплант для введения лекарственных веществ в витреальную полость глаза
RU2585728C1 (ru) Дренаж для офтальмологических операций
RU2464000C1 (ru) Способ лечения нестабилизированной первичной глаукомы
DEEP Dida Kazakova¹ 23*, Andre Mermoud and Gunther Krieglstein3
Machemer One of the most exciting developments in ophthalmology is taking place in an area that formerly received little attention. For years, most surgeons dreaded the disasters likely to occur after initially successful retinal surgery. It is only over the last 10 years or so that the problem of

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired